Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region

被引:7
|
作者
Hollingsworth, Louis R. [1 ,2 ,3 ]
Brown, Anne M. [2 ,4 ]
Gandour, Richard D. [3 ,5 ]
Bevan, David R. [2 ,3 ,5 ]
机构
[1] Virginia Tech, Dept Chem Engn, Blacksburg, VA USA
[2] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA
[3] Virginia Tech, Dept Chem, Blacksburg, VA USA
[4] Virginia Tech, Res & Informat, Univ Lib, Blacksburg, VA USA
[5] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA USA
来源
PLOS ONE | 2018年 / 13卷 / 01期
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; PARTICLE MESH EWALD; CRYO-EM STRUCTURE; MOLECULAR-DYNAMICS; ENVELOPE GLYCOPROTEINS; STRUCTURAL DYNAMICS; ENV; ANTIBODY; CONFORMATION; INFECTION;
D O I
10.1371/journal.pone.0190658
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple approaches are being utilized to develop therapeutics to treat HIV infection. One approach is designed to inhibit entry of HIV into host cells, with a target being the viral envelope glycoprotein, gp120. Polyanionic compounds have been shown to be effective in inhibiting HIV entry, with a mechanism involving electrostatic interactions with the V3 loop of gp120 being proposed. In this study, we applied computational methods to elucidate molecular interactions between the repeat unit of the precisely alternating polyanion, Poly(4,4'-stil-benedicarboxylate-alt-maleic acid) (DCSti-alt-MA) and the V3 loop of gp120 from strains of HIV against which these polyanions were previously tested (IIIb, BaL, 92UG037, JR-CSF) as well as two strains for which gp120 crystal structures are available (YU2, 2B4C). Homology modeling was used to create models of the gp120 proteins. Using monomers of the gp120 protein, we applied extensive molecular dynamics simulations to obtain dominant morphologies that represent a variety of open-closed states of the V3 loop to examine the interaction of 112 ligands of the repeating units of DCSti-alt-MA docked to the V3 loop and surrounding residues. Using the distance between the V1/V2 and V3 loops of gp120 as a metric, we revealed through MD simulations that gp120 from the lab-adapted strains (BaL and IIIb), which are more susceptible to inhibition by DCSti-alt-MA, clearly transitioned to the closed state in one replicate of each simulation set, whereas none of the replicates from the Tier II strains (92UG037 and JR-CSF) did so. Docking repeat unit microspecies to the gp120 protein before and after MD simulation enabled identification of residues that were key for binding. Notably, only a few residues were found to be important for docking both before and after MD simulation as a result of the conformational heterogeneity provided by the simulations. Consideration of the residues that were consistently involved in interactions with the ligand revealed the importance of both hydrophilic and hydrophobic moieties of the ligand for effective binding. The results also suggest that polymers of DCSti-alt-MA with repeating units of different configurations may have advantages for therapeutic efficacy.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Cryptic Determinant of α4β7 Binding in the V2 Loop of HIV-1 gp120
    Tassaneetrithep, Boonrat
    Tivon, Doreen
    Swetnam, James
    Karasavvas, Nicos
    Michael, Nelson L.
    Kim, Jerome H.
    Marovich, Mary
    Cardozo, Timothy
    PLOS ONE, 2014, 9 (09):
  • [32] Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses
    Bowder, Dane
    Thompson, Jesse
    Durst, Kate
    Hollingsead, Haley
    Hu, Duoyi
    Wei, Wenzhong
    Xiang, Shi-Hua
    VIROLOGY, 2018, 519 : 180 - 189
  • [33] Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA
    Ebenbichler, C
    McNearney, T
    Stoiber, H
    Most, J
    Zangerle, R
    Vogetseder, W
    Patsch, JR
    Ratner, L
    Dierich, MP
    MOLECULAR IMMUNOLOGY, 1995, 32 (14-15) : 1039 - 1045
  • [34] Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
    Balasubramanian, Preetha
    Williams, Constance
    Shapiro, Mariya B.
    Sinangil, Faruk
    Higgins, Keith
    Nadas, Arthur
    Totrov, Maxim
    Kong, Xiang-Peng
    Fiore-Gartland, Andrew J.
    Haigwood, Nancy L.
    Zolla-Pazner, Susan
    Hioe, Catarina E.
    SCIENTIFIC REPORTS, 2018, 8
  • [35] Interaction of sulfonated anionic porphyrins with HIV glycoprotein gp120: photodamages revealed by inhibition of antibody binding to V3 and C5 domains
    Dairou, J
    Vever-Bizet, C
    Brault, D
    ANTIVIRAL RESEARCH, 2004, 61 (01) : 37 - 47
  • [36] Computational Studies Identifying Entry Inhibitor Scaffolds Targeting the Phe43 Cavity of HIV-1 gp120
    Tintori, Cristina
    Selvaraj, Manikandan
    Badia, Roger
    Clotet, Bonaventura
    Este, Jose A.
    Botta, Maurizio
    CHEMMEDCHEM, 2013, 8 (03) : 475 - 483
  • [37] Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies
    Sharon, M
    Görlach, M
    Levy, R
    Hayek, Y
    Anglister, J
    PROTEIN EXPRESSION AND PURIFICATION, 2002, 24 (03) : 374 - 383
  • [38] Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals
    Tang, Haili
    Robinson, James E.
    Gnanakaran, S.
    Li, Ming
    Rosenberg, Eric S.
    Perez, Lautaro G.
    Haynes, Barton F.
    Liao, Hua-Xin
    LaBranche, Celia C.
    Korber, Bette T.
    Montefiori, David C.
    JOURNAL OF VIROLOGY, 2011, 85 (18) : 9286 - 9299
  • [39] A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry
    Berinyuy, Emiliene
    Soliman, Mahmoud E. S.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (02) : 119 - 129
  • [40] Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection
    Chan, Kun-Wei
    Pan, Ruimin
    Costa, Matthew
    Gorny, Miroslaw K.
    Wang, Shixia
    Lu, Shan
    Kong, Xiang-Peng
    JOURNAL OF VIROLOGY, 2018, 92 (18)